This invention relates to compounds of formula (I) ##STR00001## where R.sup.1 to R.sup.12, --W--V--, --X--Y--, p and n have the values defined in claim 1, their preparation and use as pharmaceuticals for the treatment of central nervous system disorders, such as depression, bipolar disorder, and anxiety.